Plain-English translation of NCT06449937 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether aggressively treating cancer that has spread to the liver—by surgically removing the tumors or using heat to destroy them—gives people with advanced colorectal cancer a survival advantage compared to chemotherapy alone or less invasive treatments. You would be placed into one of two groups: one that receives surgery or ablation combined with chemotherapy, or one that receives chemotherapy with or without less invasive procedures.
When colorectal cancer spreads to the liver and other parts of the body, doctors aren't certain whether removing the liver tumors surgically helps patients live longer. This trial aims to answer that important question and guide treatment decisions for people in your situation.
You likely qualify if…
You likely don't qualify if…
If enrolled, you'll be assigned to either the surgery/ablation-plus-chemotherapy group or the chemotherapy-only (or less invasive treatment) group based on your preference and your doctors' recommendations. You'll receive your assigned treatment and then return for check-up visits every three months for up to two years. During these visits, you'll have imaging scans and blood tests to monitor your progress, and you may complete quality-of-life questionnaires to help researchers understand how the treatments affect your day-to-day life.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
China